Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2020
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trialGuillaume Janoray, Yoann Pointreau, Marc Alfonsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trialMichael Henke, Marc Alfonsi, Paolo Foa, et al.
Head & Neck|June 16, 2011
Prognostic factors for T1-T2 squamous cell carcinomas of the mobile tongue: A retrospective cohort studyLaurent Bonnardot, Etienne Bardet, Olivier Steichen, et al.
The New England Journal of Medicine|September 15, 2006
Chemotherapy with preoperative radiotherapy in rectal cancerJean-François Bosset, Laurence Collette, Gilles Calais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trialEtienne Bardet, Laurent Martin, Gilles Calais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinomaFrançois Janot, Dominique de Raucourt, Ellen Benhamou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intentJacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
Cancers|December 31, 2020
Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal CancersPaul Giraud, Philippe Giraud, Eliot Nicolas, et al.
Pageof 4